Literature DB >> 18678518

Viral hepatitis in a multi-ethnic neighborhood in the Netherlands: results of a community-based study in a low prevalence country.

Irene K Veldhuijzen1, Harold F van Driel, Dieuwke Vos, Onno de Zwart, Gerard J J van Doornum, Robert A de Man, Jan Hendrik Richardus.   

Abstract

OBJECTIVES: The prevalence of viral hepatitis varies worldwide. Although the prevalence of hepatitis A virus (HAV) and hepatitis B virus (HBV) infection is generally low in Western countries, pockets of higher prevalence may exist in areas with large immigrant populations. The aim of this study was to obtain further information on the prevalence of viral hepatitis in a multi-ethnic area in the Netherlands.
METHODS: We conducted a community-based study in a multi-ethnic neighborhood in the city of Rotterdam, the Netherlands, including both native Dutch and migrant participants, who were tested for serological markers of hepatitis A, hepatitis B, and hepatitis C infection.
RESULTS: Markers for hepatitis A infection were present in 68% of participants. The prevalence of hepatitis B core antibodies (anti-HBc), a marker for previous or current infection, was 20% (58/284). Prevalence of hepatitis A and B varied by age group and ethnicity. Two respondents (0.7%) had chronic HBV infection. The prevalence of hepatitis C was 1.1% (3/271). High levels of isolated anti-HBc were found.
CONCLUSIONS: We found a high prevalence of (previous) viral hepatitis infections. This confirms previous observations in ethnic subgroups from a national general population study and illustrates the high burden of viral hepatitis in areas with large immigrant populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18678518     DOI: 10.1016/j.ijid.2008.05.1224

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  15 in total

Review 1.  Vaccinations in migrants and refugees: a challenge for European health systems. A systematic review of current scientific evidence.

Authors:  Daniele Mipatrini; Paola Stefanelli; Santino Severoni; Giovanni Rezza
Journal:  Pathog Glob Health       Date:  2017-02-06       Impact factor: 2.894

Review 2.  Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.

Authors:  Claus Niederau
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

3.  Cultural tailoring for the promotion of hepatitis B screening in Turkish Dutch: a protocol for a randomized controlled trial.

Authors:  Ytje J J van der Veen; Onno de Zwart; Johan Mackenbach; Jan Hendrik Richardus
Journal:  BMC Public Health       Date:  2010-11-05       Impact factor: 3.295

4.  Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain.

Authors:  Santiago Pérez Cachafeiro; Ana María Caro-Murillo; Juan Berenguer; Ferran Segura; Felix Gutierrez; Francesc Vidal; Maria Angeles Martinez-Perez; Julio Sola; Roberto Muga; Santiago Moreno
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

5.  The Spatial Distribution of Hepatitis C Virus Infections and Associated Determinants--An Application of a Geographically Weighted Poisson Regression for Evidence-Based Screening Interventions in Hotspots.

Authors:  Boris Kauhl; Jeanne Heil; Christian J P A Hoebe; Jürgen Schweikart; Thomas Krafft; Nicole H T M Dukers-Muijrers
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240

Review 6.  Are the testing needs of key European populations affected by hepatitis B and hepatitis C being addressed? A scoping review of testing studies in Europe.

Authors:  Jeffrey V Lazarus; Ida Sperle; Alexander Spina; Jürgen K Rockstroh
Journal:  Croat Med J       Date:  2016-10-31       Impact factor: 1.351

7.  Hepatitis C virus prevalence in The Netherlands: migrants account for most infections.

Authors:  H J Vriend; M G Van Veen; M Prins; A T Urbanus; H J Boot; E L M Op De Coul
Journal:  Epidemiol Infect       Date:  2012-09-11       Impact factor: 4.434

8.  Clinical practice of hepatitis B screening in patients starting with chemotherapy: A survey among Dutch oncologists.

Authors:  Karin Leber; Hans-Martin J M M B Otten; Dees P M Brandjes; Mark A A Claassen; Fanny N Lauw
Journal:  Eur J Cancer Care (Engl)       Date:  2021-07-26       Impact factor: 2.328

Review 9.  Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening.

Authors:  Susan J M Hahné; Irene K Veldhuijzen; Lucas Wiessing; Tek-Ang Lim; Mika Salminen; Marita van de Laar
Journal:  BMC Infect Dis       Date:  2013-04-18       Impact factor: 3.090

10.  Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.

Authors:  A M Falla; A A Ahmad; E Duffell; T Noori; I K Veldhuijzen
Journal:  BMC Infect Dis       Date:  2018-01-16       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.